Cargando…
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
Cannabis and analogs of Δ(9)-tetrahydrocannabinol have been used for therapeutic purposes, but their therapeutic use remains limited because of various adverse effects. Endogenous cannabinoids have been discovered, and dysregulation of endocannabinoid signaling is implicated in the pathophysiology o...
Autores principales: | Ogawa, Shintaro, Kunugi, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759315/ https://www.ncbi.nlm.nih.gov/pubmed/26630956 http://dx.doi.org/10.2174/1570159X13666150612225212 |
Ejemplares similares
-
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021) -
Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates
as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase,
and Butyrylcholinesterase: Structure–Activity Relationships
and Hydrolytic Stability
por: Rudolph, Stefan, et al.
Publicado: (2021) -
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses
por: Wang, Y, et al.
Publicado: (2017) -
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
por: Deplano, Alessandro, et al.
Publicado: (2019) -
Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants
por: Zada, Wahid, et al.
Publicado: (2022)